Today, Bank of New York Mellon Corp decides to keep it stake in UnitedHealth Group Inc. (UNH) to the level of $1,561,082,000

Today, Bank of New York Mellon Corp decides to keep it stake in UnitedHealth Group Inc. (UNH) to the level of $1,561,082,000
Bank of New York Mellon Corp increased its stake in UnitedHealth Group Inc. (NYSE:UNH) by 2.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,150,584 shares of the healthcare conglomerate’s stock after buying an additional 317,180 shares during the period. Bank of New York Mellon Corp owned approximately 1.15% of UnitedHealth Group worth $1,561,082,000 as of its most recent filing with the SEC.

Several other hedge funds also recently added to or reduced their stakes in the company. Van Hulzen Asset Management LLC acquired a new stake in UnitedHealth Group during the second quarter valued at $104,000. Archford Capital Strategies LLC raised its stake in UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 696 shares during the period. NewSquare Capital LLC raised its stake in UnitedHealth Group by 4.8% in the third quarter. NewSquare Capital LLC now owns 880 shares of the healthcare conglomerate’s stock valued at $123,000 after buying an additional 40 shares during the period. Adirondack Trust Co. raised its stake in UnitedHealth Group by 16.4% in the third quarter. Adirondack Trust Co. now owns 885 shares of the healthcare conglomerate’s stock valued at $124,000 after buying an additional 125 shares during the period. Finally, Hanson McClain Inc. raised its stake in UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $126,000 after buying an additional 4 shares during the period. 86.04% of the stock is currently owned by institutional investors.

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.48% on Friday, hitting $152.81. The company had a trading volume of 1,664,542 shares. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $154.50. The firm’s 50 day moving average price is $142.75 and its 200-day moving average price is $139.46. The stock has a market capitalization of $145.45 billion, a PE ratio of 22.57 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.09. The business earned $46.30 billion during the quarter, compared to analyst estimates of $46.09 billion. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. UnitedHealth Group’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.77 EPS. Analysts forecast that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Friday, December 2nd will be given a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date of this dividend is Wednesday, November 30th. UnitedHealth Group’s payout ratio is 36.93%.

Several research firms recently weighed in on UNH. Leerink Swann reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday. Mizuho lowered UnitedHealth Group from a “buy” rating to a “neutral” rating in a research note on Wednesday, November 9th. Credit Suisse Group AG reaffirmed an “outperform” rating and issued a $160.00 price objective (up from $155.00) on shares of UnitedHealth Group in a research note on Friday, October 21st. Vetr lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $144.66 price objective on the stock. in a research note on Tuesday, October 18th. Finally, Jefferies Group reaffirmed a “buy” rating and issued a $163.00 price objective on shares of UnitedHealth Group in a research note on Sunday, October 16th. Two analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $158.03.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 325 shares of the company’s stock in a transaction that occurred on Friday, October 21st. The stock was sold at an average price of $144.99, for a total transaction of $47,121.75. Following the completion of the transaction, the director now owns 28,613 shares of the company’s stock, valued at approximately $4,148,598.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,460 shares of the company’s stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $150.55, for a total value of $822,003.00. Following the transaction, the director now directly owns 60,052 shares of the company’s stock, valued at approximately $9,040,828.60. The disclosure for this sale can be found here. Company insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

Related posts

Leave a Comment